FDA Inspection
Valjean CorporationValjean Corporation – FDA Inspection, Nov 30, 2012
Record Details
This FDA Inspection record concerns Valjean Corporation, with an inspection on November 30, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Valjean Corporation
- Inspection Date
- November 30, 2012
- Product Type
- Drugs
View Company Profile
ID · b81de3af-41c3-4ac8-a880-f4ef8ace7143
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 809103
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.170(b)Annual visual exams of drug products
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(b)Written procedures fail to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Valjean Corporation
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 10, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Valjean Corporation
- FDA Inspection 974098 - 2016-06-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.